The literature outruns any team.
Publications, preprints, and trial registrations compound daily. The competitive picture you present internally is only as fresh as the last manual review.

Operations led · intelligence under governance
Life sciences companies run on documents and vigilance: literature, trial landscapes, regulatory correspondence, medical review. We orchestrate that load with agentic systems that read continuously, prepare rigorously, and put every output through the review your industry demands. Your scientists and medical teams decide. The system does the reading.
Publications, preprints, and trial registrations compound daily. The competitive picture you present internally is only as fresh as the last manual review.
Medical, legal, and regulatory review exists for good reason and it cannot be rushed. What can change is the quality of what enters the queue: prepared, referenced, and pre checked material moves through in a fraction of the cycles.
Regulatory, medical affairs, market access, and BD all run on assembling and summarizing documents. That is precisely the work agents do without fatigue.
Step 01
Agents monitor publications, trial registries, conference abstracts, and competitor announcements continuously, mapped to your assets and targets.
Step 02
Raw signal becomes structured briefs: what moved, what it means for your program, and what the source actually says, with citations attached.
Step 03
Draft materials arrive referenced and pre checked against your claims library and style, built to enter review clean rather than bounce.
Step 04
Your medical and regulatory reviewers hold the gate, with the full evidence trail one click away. Nothing represents the company without a qualified human yes.

01
A continuously updated view of the competitive landscape: trial starts, readouts, publications, and conference signal, briefed weekly and on trigger events.
02
Scientific communications, congress materials, and response documents drafted with references resolved, built for the MLR queue.
03
Agents assemble, cross check, and format submission components and correspondence from your source documents, prepared for expert review.
04
Target and landscape research assembled from public scientific and financial signal, structured the way your BD team already works.
In this industry an unsourced claim is not a typo, it is a finding. Every output carries its references, every summary links to its sources, and the system is designed so nothing that represents the company can bypass qualified review. We build for the audit, the inspection, and the scientist who asks where a sentence came from.
This is for biotech and life sciences companies where small teams carry document loads built for departments: emerging biopharma, diagnostics, and platform companies between first readouts and commercial scale. If your scientists spend evenings summarizing instead of thinking, that is the leak.
A 30 minute working session. We map your document and vigilance load, and show what continuous, governed intelligence looks like for your program.